Medical Developments International (MDI)
Emily Robertson is an experienced professional in quality systems, currently serving as a Quality Systems Associate at Medical Developments International (MDI) since August 2022. Prior to this role, Emily held the position of QA Production Associate at Cell Therapies Pty Ltd for a brief period in April to May 2022 and spent over six years as a Design & Quality Support Officer at Haemokinesis from February 2016 to April 2022. Emily obtained a Bachelor of Biomedical Science (Laboratory Medicine) from RMIT University, completing the degree in 2015, and attended Dromana Secondary College from 2006 to 2011.
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.